Financials
- Market Capitalization 1.57 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.15
Rapporto prezzo/fatturato
170.48
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2146 | BCAX Bicara Therapeutics Inc. - Common Stock | 24.83 USD | +0.40% | +0.40% | -7.63% | +71.95% | 1.64 B USD | ||
| 2150 | FBRX Forte Biosciences, Inc. - Common Stock | 76.99 USD | 0.00% | +0.08% | +0.50% | +162.32% | 1.63 B USD | ||
| 2173 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.48 USD | -1.40% | -2.53% | +3.04% | +7.21% | 1.55 B USD | ||
| 2175 | TYRA Tyra Biosciences, Inc. - Common Stock | 25.70 USD | -1.65% | -3.24% | -17.94% | +79.22% | 1.53 B USD |